Not Signed In -
Caffeine Tablets |
Caffedrine; Enerjets; NoDoz; Vivarin |
Vivarin is an over-the-counter caffeine tablet from GlaxoSmithKline which is used to restore mental alertness or wakefulness when experiencing fatigue or drowsiness. Vivarin contains 200 mg. of caffeine per tablet or caplet, approximately the same amount of caffeine found in a cup of coffee. ...
Wikipedia - [full article]
Caffeine Tablets Clinical Trials
- Assessment and Treatment of Caffeine Dependence
ClinicalTrials.gov Identifier: NCT00338195 - Recruiting
Self-Identified Problematic Caffeine Use; DSM-IV Substance Dependence as Applied to Caffeine
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
Pain
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
Parkinson's Disease
- Oxycodone-Naloxone Prolonged Release Tablets in Relieving Opioid-Related Constipation
ClinicalTrials.gov Identifier: NCT00412100 - Active, not recruiting
Pain
- Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
ClinicalTrials.gov Identifier: NCT00205166 - Recruiting
Coronary Artery Disease
- Dextro-Amphetamine Versus Caffeine in Treatment-Resistant OCD
ClinicalTrials.gov Identifier: NCT00363298 - Recruiting
Obsessive-Compulsive Disorder
- An Open-Label Evaluation of the Dose Proportionality of OROS® Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
ClinicalTrials.gov Identifier: NCT00398957 - Active, not recruiting
Analgesia
- Phase III Study to Assess the Long Term Efficacy, Carry-Over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets
ClinicalTrials.gov Identifier: NCT00418379 - Active, not recruiting
Allergy
- Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
Transplantation; Kidney Transplantation; Immunosuppression
- Long-Term Administration Study of SND 919 Tablets in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00274131 - Active, not recruiting
Parkinson Disease
- Changes in the Immune Response and Skin Reactivity of Grass Pollen Allergic Patients Treated With ALK Grass Tablets
ClinicalTrials.gov Identifier: NCT00413556 - Active, not recruiting
Allergy
- Caffeine for Apnea of Prematurity (CAP)
ClinicalTrials.gov Identifier: NCT00182312 - Active, not recruiting
Apnea of Prematurity
- A Study of Relapse Prevention and the Effectiveness of Long-Acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schiozaffective Disorder
ClinicalTrials.gov Identifier: NCT00216476 - Active, not recruiting
Schizophrenia; Psychotic Disorders
- A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410878 - Active, not recruiting
Analgesics, Opioid.; Pain
- Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients
ClinicalTrials.gov Identifier: NCT00495092 - Recruiting
Cocaine Related Disorders
- Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00324961 - Active, not recruiting
Chronic Hepatitis B
- A Study of the Efficacy and Safety of Long-Acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00240708 - Active, not recruiting
Schizophrenia
- The Impact of Caffeine on Brachial Endothelial Function in Healthy Subjects and in Patients With Ischemic Heart Disease
ClinicalTrials.gov Identifier: NCT00564824 - Recruiting
Coronary Disease
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
Epilepsy, Partial
- Lopinavir Capsules to Kaletra or Invirase Tablets
ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
HIV Infections
- Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets
ClinicalTrials.gov Identifier: NCT00553865 - Recruiting
Essential Hypertension
- A MULTICENTER, OPEN-LABEL, RANDOMIZED CROSSOVER TRIAL TO ASSESS SUBJECT PREFERENCE FOR ALPRAZOLAM ORALLY DISINTEGRATING TABLETS COMPARED TO CONVENTIONAL ALPRAZOLAM TABLETS IN SUBJECTS WITH ANXIETY
ClinicalTrials.gov Identifier: NCT00139854 - Completed
Anxiety
- Coronary Care Caffeine
ClinicalTrials.gov Identifier: NCT00137098 - Completed
Myocardial Infarction
- The Effect of Caffeine on Ischemic Preconditioning
ClinicalTrials.gov Identifier: NCT00184912 - Completed
Caffeine; Ischemic Preconditioning; Ischemia-Reperfusion Injury
- Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1
ClinicalTrials.gov Identifier: NCT00396149 - Recruiting
Allergy
- A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
ClinicalTrials.gov Identifier: NCT00326300 - Active, not recruiting
Attention Deficit Hyperactivity Disorder
- Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
ClinicalTrials.gov Identifier: NCT00471952 - Recruiting
Migraine With Aura; Migraine Without Aura
- Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis
ClinicalTrials.gov Identifier: NCT00409409 - Recruiting
Allergy
- Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
Onychomycosis of the Toenail
- Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain
ClinicalTrials.gov Identifier: NCT00463047 - Recruiting
Chronic Pain
- Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients
ClinicalTrials.gov Identifier: NCT00541385 - Recruiting
Malaria
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
Alzheimer Disease
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
Schizophrenia; Bipolar Disorder
- Does Caffeine Reduce Rosuvastatin-Induced Protection Against Ischemia-Reperfusion Injury?
ClinicalTrials.gov Identifier: NCT00457652 - Recruiting
Ischemia Reperfusion Injury
- Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
Seasonal Allergic Rhinoconjunctivitis
- Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With ITP
ClinicalTrials.gov Identifier: NCT00441090 - Recruiting
Chronic Idiopathic Thrombocytopenic Purpura (ITP)
- Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov Identifier: NCT00086203 - Active, not recruiting
Chronic Lymphocytic Leukemia
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141557 - Recruiting
Menopause
- A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
HIV Infection
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
Alzheimer's Disease
- Does Caffeine Help Children With Obstructive Sleep Apnea Recover Faster From Anesthesia and With Less Complication After Tonsillectomy and Adenoidectomy?
ClinicalTrials.gov Identifier: NCT00273754 - Recruiting
Sleep Apnea, Obstructive; Tonsillectomy and Adenoidectomy; Postoperative Complications
- A Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Dosing in Antiretroviral-Experienced, HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00358917 - Recruiting
HIV Infection
- The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141544 - Recruiting
Menopause
- Long-Term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
ClinicalTrials.gov Identifier: NCT00263575 - Recruiting
Pain; Cancer
- Caffeine and Intermittent Claudication
ClinicalTrials.gov Identifier: NCT00388128 - Recruiting
Intermittent Claudication
- Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
ClinicalTrials.gov Identifier: NCT00262678 - Recruiting
Pain; Cancer
- Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis
ClinicalTrials.gov Identifier: NCT00543426 - Recruiting
Posthepatitic Cirrhosis
- Post Marketing Surveillance Study to Observe Safety and Efficacy of Champix® Tablets
ClinicalTrials.gov Identifier: NCT00483002 - Not yet recruiting
Smoking Cessation
- Efficacy of Caffeine, With and Without Biperiden, as a Maintenance Treatment for Cocaine Dependence
ClinicalTrials.gov Identifier: NCT00495183 - Not yet recruiting
Cocaine Dependence
- Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn''s Disease
ClinicalTrials.gov Identifier: NCT00130390 - Recruiting
Crohn''s Disease
- Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.
ClinicalTrials.gov Identifier: NCT00305071 - Not yet recruiting
Pyuria; Urinary Tract Infections
- The Effect of Caffeine in Elderly Citizens
ClinicalTrials.gov Identifier: NCT00117520 - Completed
Healthy elderly citizens
- Caffeine in the Prevention of Post-Operative Nausea and Vomiting
ClinicalTrials.gov Identifier: NCT00130026 - Completed
POSTOP NAUSEA VOMITING
- Study of TLK199 Tablets in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov Identifier: NCT00280631 - Recruiting
Myelodysplastic Syndrome (MDS)
- Caffeine for Excessive Daytime Somnolence in Parkinson's Disease
ClinicalTrials.gov Identifier: NCT00459420 - Recruiting
Parkinson's Disease; Excessive Daytime Somnolence
- Effects of Cranberry-Containing Products in Women with Recurrent Urinary Tract Infections (UTIs)
ClinicalTrials.gov Identifier: NCT00100061 - Recruiting
Urinary Tract Infection
- A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
Restless Legs Syndrome
- Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)
ClinicalTrials.gov Identifier: NCT00434304 - Not yet recruiting
Parkinson's Disease
- Smoking Cessation With Smokeless Tobacco, Nicotine Tablets and Nicotine Patches
ClinicalTrials.gov Identifier: NCT00313105 - Not yet recruiting
Tobacco Dependence
- Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
ClinicalTrials.gov Identifier: NCT00556894 - Not yet recruiting
Rheumatoid Arthritis
- A Multicenter, Open-Label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects with Stable Parkinson''s Disease
ClinicalTrials.gov Identifier: NCT00139867 - Completed
Parkinson''s Disease
- Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
Epilepsy
- Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
Restless Legs Syndrome
- Experimental Studies of the Effects of Caffeine on Glucose Regulation
ClinicalTrials.gov Identifier: NCT00432887 - Completed
Diabetes Mellitus, Type 2
- Effects of Low Doses of Caffeine on Mood, Physiology and Mental Function
ClinicalTrials.gov Identifier: NCT00487227 - Completed
Healthy
- Effects of Kava on the Body's Elimination of Caffeine and Dextromethorphan
ClinicalTrials.gov Identifier: NCT00009542 - Completed
Healthy
- Intravenous azithromycin plus intravenous ceftriaxone followed by oral azithromycin with intravenous levofloxacin followed by oral levofloxacin for the treatment of moderate to severely ill hospitalized patients with community acquired pneumonia.
ClinicalTrials.gov Identifier: NCT00035347 - Completed
Pneumonia
- Mefloquine Bioequivalence Among 3 Commercially Available Tablets.
ClinicalTrials.gov Identifier: NCT00544024 - Completed
Malaria
- Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
ClinicalTrials.gov Identifier: NCT00062556 - Completed
Intermittent Claudication; Peripheral Vascular Disease
- Determining the Risk Factors such as Smoking, Alcohol, and Caffeine and their Association with Osteoporosis in Men
ClinicalTrials.gov Identifier: NCT00011323 - Completed
Osteoporosis
- Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
ClinicalTrials.gov Identifier: NCT00328718 - Completed
Asthma
- Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00396799 - Completed
Menopause
- Study Comparing Premarin® Vaginal Cream Versus Premarin® Oral Tablets in Atrophic Vaginitis
ClinicalTrials.gov Identifier: NCT00167921 - Completed
Atrophic Vaginitis
- A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.
ClinicalTrials.gov Identifier: NCT00500201 - Completed
Schizophrenia
- Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets
ClinicalTrials.gov Identifier: NCT00550329 - Completed
Diabetes Mellitus, Non-Insulin-Dependent; Hyperglycemia
- Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects
ClinicalTrials.gov Identifier: NCT00255528 - Completed
Hypertension
- A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
ClinicalTrials.gov Identifier: NCT00232154 - Completed
Sinusitis
- An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen
ClinicalTrials.gov Identifier: NCT00344383 - Completed
Metrorrhagia
- Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
ClinicalTrials.gov Identifier: NCT00430170 - Completed
Cardiovascular Disease; Ischemia-Reperfusion Injury
- Micronutrients and Enteric Infections in African Children
ClinicalTrials.gov Identifier: NCT00156832 - Completed
Diarrhea
- The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
ClinicalTrials.gov Identifier: NCT00195741 - Completed
Migraine
- A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
ClinicalTrials.gov Identifier: NCT00268827 - Completed
HIV-1; AIDS
- Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00343629 - Completed
Unspecified Adult Solid Tumor, Protocol Specific
- A Study Comparing the Efficacy of Long-Acting Injectable Risperidone and Olanzapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
ClinicalTrials.gov Identifier: NCT00236457 - Completed
Schizophrenia; Psychotic Disorders
- Follow-up Study of Patients Previously Treated with Pimecrolimus Tablets for Chronic Plaque-type Psoriasis
ClinicalTrials.gov Identifier: NCT00098189 - Completed
Psoriasis
- Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
ClinicalTrials.gov Identifier: NCT00387010 - Completed
Pain
- A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
ClinicalTrials.gov Identifier: NCT00225810 - Completed
Crohn's Disease
- A Comparison of the Effectiveness and Safety of Injectable Risperidone With That of Risperidone Tablets in the Treatment of Patients With Chronic Schizophrenia
ClinicalTrials.gov Identifier: NCT00249223 - Completed
Schizophrenia; Psychotic Disorders
- An Open-Label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-Dissolving Tablet Formulation of Risperdone
ClinicalTrials.gov Identifier: NCT00246272 - Completed
Schizophrenia
- Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00195767 - Completed
Bipolar I Disorder, Manic or Mixed
- Study of Fampridine-SR Tablets in Multiple Sclerosis Patients
ClinicalTrials.gov Identifier: NCT00483652 - Completed
Multiple Sclerosis
- Evaluation of the Usefulness to Doctors of the Risperdal® Consta® Treatment Guidebook Over a Three-Month Period During Which Adult Patients With Schizophrenia or Schizoaffective Disorder Are Switching From Daily Doses or Risperidone Tablets to Long-Acti
ClinicalTrials.gov Identifier: NCT00236548 - Completed
Psychotic Disorders; Schizophrenia
- Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The Esophagus
ClinicalTrials.gov Identifier: NCT00259987 - Completed
Adenocarcinoma
- Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00141570 - Completed
Menopause
- Study Comparing Lecozotan SR Two 5-mg Tablets Vs. Lecozotan SR One 10-mg Tablet in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00494962 - Completed
Alzheimer Disease
- Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
ClinicalTrials.gov Identifier: NCT00300378 - Completed
Depressive Disorder, Major
- FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
ClinicalTrials.gov Identifier: NCT00064441 - Completed
Ulcerative Colitis
- FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
ClinicalTrials.gov Identifier: NCT00064454 - Completed
Ulcerative Colitis
- An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00060905 - Completed
Bipolar Disorder
Resources
- Caffedrine (Drug Digest)
- Caffeine Tablets (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
